349
Participants
Start Date
December 31, 2011
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2019
OPT-822/OPT-821(30 μg/100 μg)
Subcutaneously on week 1, 2, 3, 5, 9, 13, 17, 25, and 37. OPT-822 and OPT-821 are combined at time of injection.
Phosphate Buffer Saline (PBS)
Subcutaneously on week 1, 2, 3, 5, 9, 13, 17, 25, and 37.
Cyclophosphamide
Subcutaneously on week 1, 2, 3, 5, 9, 13, 17, 25, and 37.
Weill Cornell Medical College, New York
Hope Women's Cancer Center, Asheville
Memorial Regional Hospital, Hollywood
The University of Alabama at Birmingham (UAB), Birmingham
University of Chicago Medical Center, Chicago
University of Texas MD Anderson Cancer Center, Houston
University of California, Los Angeles (UCLA), Santa Monica
University of California, San Diego (UCSD), La Jolla
St. Jude Heritage Healthcare, Virginia K. Crosson Cancer Center, Fullerton
University of California, Irvine (UCI), Orange
Coastal Integrative Cancer Care, San Luis Obispo
Central Coast Medical Oncology Corporation, Santa Maria
University of California, San Francisco (UCSF), San Francisco
UNIMED Medical Institute, Hong Kong
HCG, Bangalore Institute of Oncology, Bengaluru
Curie Manavata Cancer Centre, Mumbai
Dong-A University Hospital, Busan
Pusan National University Hospital, Busan
Inha University Hospital, Chungcheongbuk-Do
National Cancer Center, Chungcheongbuk-Do
Kyungpook National University Medical Center, Daegu
Yeungnam University Medical Center, Daegu
Asan Medical Center, Seoul
Korea University Anam Hospital, Seoul
Seoul National University Hospital ,, Seoul
Seoul St. Mary's Hospital, Seoul
Severance Hospital, Seoul
Changhua Christian Hospital, Changhua
Chang Gung Memorial Hospital-KS, Kaohsiung City
Kaohsiung Medical University Hospital, Kaohsiung City
Kaohsiung Veterans General Hospital, Kaohsiung City
Chang Gung Memorial Hospital -Linkou, Linkou District
Mackay Memorial Hospital, New Taipei City
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Chi Mei Medical Center, Tainan City
National Cheng Kung University Hospital, Tainan City
Chang Gung Memorial Hospital-Taipei, Taipei
Koo Foundation Sun Yat-Sen Cancer Center, Taipei
National Taiwan University Hospital, Taipei
Shuang-Ho Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
Lead Sponsor
OBI Pharma, Inc
INDUSTRY